Myosin post-translational modifications and function in the presence of myopathy-linked truncating MYH2 mutations
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myosin post-translational modifications and function in the presence of myopathy-linked truncating MYH2 mutations
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 324, Issue 3, Pages C769-C776
Publisher
American Physiological Society
Online
2023-02-07
DOI
10.1152/ajpcell.00002.2023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Post-translational modification patterns on β-myosin heavy chain are altered in ischemic and nonischemic human hearts
- (2022) Maicon Landim-Vieira et al. eLife
- NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy
- (2022) Natasha Ranu et al. Acta Neuropathologica Communications
- Filamentous tangles with nemaline rods in MYH2 myopathy: a novel phenotype
- (2021) Nicolas N. Madigan et al. Acta Neuropathologica Communications
- The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
- (2021) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Myofibre Hyper-Contractility in Horses Expressing the Myosin Heavy Chain Myopathy Mutation, MYH1E321G
- (2021) Julien Ochala et al. Cells
- Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy
- (2020) Christopher N. Toepfer et al. CIRCULATION
- MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form
- (2020) Roberta Telese et al. Molecular Genetics & Genomic Medicine
- rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy
- (2020) Jacob A. Ross et al. Acta Neuropathologica Communications
- Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
- (2019) Christopher N. Toepfer et al. Science Translational Medicine
- Impairments in contractility and cytoskeletal organisation cause nuclear defects in nemaline myopathy
- (2019) Jacob A. Ross et al. ACTA NEUROPATHOLOGICA
- Congenital myopathies: disorders of excitation–contraction coupling and muscle contraction
- (2018) Heinz Jungbluth et al. Nature Reviews Neurology
- Myopathy-inducing mutation H40Y in ACTA1 hampers actin filament structure and function
- (2016) Chun Chan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness
- (2016) Tracey Willis et al. JOURNAL OF NEUROLOGY
- Myosin myopathy with external ophthalmoplegia associated with a novel homozygous mutation inMYH2
- (2016) Aurelio Hernández-Laín et al. MUSCLE & NERVE
- Protein modification and maintenance systems as biomarkers of ageing
- (2015) Valerie Vanhooren et al. MECHANISMS OF AGEING AND DEVELOPMENT
- MYH2 mutation in recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12
- (2013) Alexander Lossos et al. BRAIN
- Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations
- (2013) Homa Tajsharghi et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Myosinopathies: pathology and mechanisms
- (2012) Homa Tajsharghi et al. ACTA NEUROPATHOLOGICA
- A New State of Cardiac Myosin with Very Slow ATP Turnover: A Potential Cardioprotective Mechanism in the Heart
- (2011) Pleuni Hooijman et al. BIOPHYSICAL JOURNAL
- Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations
- (2010) Homa Tajsharghi et al. BRAIN
- Myosin ATP turnover rate is a mechanism involved in thermogenesis in resting skeletal muscle fibers
- (2009) M. A. Stewart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started